PNT Insider Trading Activity and SEC Form 4 Filings
PNT insider trading summary
No open-market insider purchases or sales of POINT Biopharma Global Inc. (PNT) have been reported on SEC Form 4 in the past 12 months.
Latest PNT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 18, 2023 | Bvf I Gp LLC | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Biotechnology Value Fund L P | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Biotechnology Value Fund II LP | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Bvf II Gp LLC | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | BVF Partners OS Ltd. | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Bvf Gp Holdings LLC | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Bvf Inc/Il | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Mark N Lampert | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
| Dec 18, 2023 | Bvf Partners L P/Il | Insider | Sell | $111.7M (8,974,245 @ $12.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.